As published in the Journal of Medical Physics, a NovaScan prototype in breast assessment was employed in a 350 patient study for the detection of breast cancer. NovaScan’s results were unparalleled: 100% sensitivity and 85%+ specificity across 350 patients.
The NovaScan FastScan device detects the presence of cancer, on or near the device, in 0.07 seconds. It is compact, and simple to operate. It also does not require capital equipment.
The NovaScan FastScan is not cleared for sale in the United States.